Back
Relay Therapeutics Vs. Inhibrx Biosciences Industry Stock Comparison
Sell
18
RLAY
Relay Therapeutics
Last Price:
4.66
Seasonality Move:
-6.4%
Buy
54
INBX
Inhibrx Biosciences
Last Price:
14.15
Seasonality Move:
--
Sell
18
Relay Therapeutics (RLAY)
is a Sell
Is Relay Therapeutics a Buy, Sell or Hold?
- The current Relay Therapeutics [RLAY] share price is $4.66. The Score for RLAY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
- RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Buy
54
Inhibrx Biosciences (INBX)
is a Buy
Is Inhibrx Biosciences a Buy, Sell or Hold?
- The current Inhibrx Biosciences [INBX] share price is $14.04. The Score for INBX is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.
- INBX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RLAY Stock Price Chart
What is Relay Therapeutics's stock price today?
-
The Relay Therapeutics share price today is $4.66
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight buying pressure.
INBX Stock Price Chart
What is Inhibrx Biosciences's stock price today?
-
The Inhibrx Biosciences share price today is $14.04
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and INBX is experiencing slight selling pressure.
RLAY Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.42 | Sell |
Relative Strength Index (14 RSI): | 23.85 | Sell |
Chaikin Money Flow: | 194739 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.35 - 6.45) | Sell |
Bollinger Bands (100): | (5.96 - 8) | Sell |
INBX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.4 | Sell |
Relative Strength Index (14 RSI): | 37.96 | Sell |
Chaikin Money Flow: | -41514 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.71 - 16.33) | Sell |
Bollinger Bands (100): | (13.09 - 16.09) | Sell |
RLAY Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.37 | Sell |
20-day SMA: | 5.73 | Sell |
50-day SMA: | 6.5 | Sell |
200-day SMA: | 7.36 | Sell |
8-day EMA: | 5.22 | Sell |
20-day EMA: | 5.69 | Sell |
50-day EMA: | 6.26 | Sell |
200-day EMA: | 7.52 | Sell |
INBX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.77 | Sell |
20-day SMA: | 15.44 | Sell |
50-day SMA: | 15.68 | Sell |
200-day SMA: | 0 | Buy |
8-day EMA: | 14.58 | Sell |
20-day EMA: | 15.15 | Sell |
50-day EMA: | 15.29 | Sell |
200-day EMA: | 2.13 | Buy |
Relay Therapeutics Earnings Growth & RLAY Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.
Inhibrx Biosciences Earnings Growth & INBX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Relay Therapeutics Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Inhibrx Biosciences Technical Analysis
Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | Nov 18 | Nov 19 | Nov 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
07 | 08 | 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |